Sponsors

Lead Sponsor

University of Alabama at Birmingham

This study will use a three-arm randomized control trial design. Eligible and consented participants will be assigned to one of three groups: (1) intervention with high-tech support, (2) intervention with low-tech support, and (3) attention-control group. The active intervention period will include six months of weekly health coaching calls and technology access. The low-tech support group will receive six months of weekly coaching calls and weekly email containing related materials in PDF format but no video and technology content.

Related studies

RECRUITING

An Observational Study Called FINE-REAL Korea to Learn More About the Use of the Drug Finerenone in People With Chronic Kidney Disease and Type 2 Diabetes in a Routine Medical Care Setting in South Korea

NCT07232537 · Chronic Kidney Disease, Type 2 Diabetes Mellitus

View all related studies →

Medical Nutrition Therapy and Diabetes Self-Management Education for People With Disabilities

What this study is about

Save this trial guide to your notes

Sponsors

Related studies

Visceral Adipose Tissue and Liver Changes Associated With Semaglutide in CKD

Effect of Early Combination Antihyperglycemic Treatment on Metabolic Control in Individuals With Type 2 Diabetes

Using Virtual Reality to Improve Medical Training

Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass

An Observational Study Called FINE-REAL Korea to Learn More About the Use of the Drug Finerenone in People With Chronic Kidney Disease and Type 2 Diabetes in a Routine Medical Care Setting in South Korea

Trial snapshot

Condition

Locations shown

For caregivers